2021 Immunity News Updates—Could One Vitamin Help Reduce Mortality Rates?
In this article:
- What Is Vitamin D3?
- What Are The General Health Benefits Of Vitamin D3?
- Is Vitamin D3 Deficiency Common?
- What Are The Risk Factors for Vitamin D3 Deficiency?
- Effects Of Vitamin D3 On Viral Respiratory Infections
- Effects Of Vitamin D3 On Reducing Mortality In Viral Respiratory Infections
- Vitamin D Supplementation As A Public Health Strategy
There is obviously a considerable focus on immune function in fighting viral illness right now. Not only in our personal lives, but also in medical research. In particular, there is a lot of exciting research coming out about vitamin D3 and its importance in the ability of the immune system to fight off viruses, especially at the right dosage.
Vitamin D3 is called the “sunshine vitamin” because sunlight hitting our skin changes a compound (7-dehydrocholesterol) in the exposed area of skin into vitamin D3. This form of vitamin D is also available as a dietary supplement. Twenty to thirty minutes of mid-day exposure to sunlight on a large portion of exposed skin can produce about 10,000 to 20,000 IU of vitamin D3.
Once the skin forms D3 or it is ingested as a supplement it is transported to the liver and converted by an enzyme into 25-hydroxyvitamin D3 or 25-OH-D3. When you get a blood test for vitamin D3 it is this form that is being measured. 25-OH-D3 is then converted to 1,25-OH2-D3 in the kidneys. This form is the most potent form and is about ten times more potent than vitamin D3.
Liver issues, including the common liver issue that occurs in people who have type 2 diabetes and/or obesity (non-alcoholic fatty liver), can lead to lower blood levels of 25-OH-D3 even if the intake of vitamin D3 is sufficient because of impaired conversion of D3 by the liver. Problems with the kidneys lead to low levels of 1,25-OH2-D3 and that can have a negative effect on calcium metabolism and bone health.
Vitamin D3 has several important functions in the body. Most people know that it is important for the normal growth and development of bones and teeth, as well as being important for the immune system. But vitamin D3’s benefits go well beyond these basics. Scientists have identified nearly 2,700 genes that vitamin D3’s metabolites are critical in binding to and regulating, including the largest number of these genes involving influencing white blood cell function.
Low levels of vitamin D3 are linked to not only the risk of developing bone abnormalities and poor immune function, but also many other issues including heart disease, autoimmune disorders, low mood and feelings of stress, poor blood sugar control, and accelerated aging.
A large amount of research has shown that vitamin D deficiency occurs throughout the world. Many health experts believe that wide-spread vitamin D supplementation may be the most important and cost-effective public health strategy for improving health, reducing disease, and helping people to live longer. Those severely deficient in vitamin D experience significantly shorter lives (by at least 7 years!) and have twice the risk for many chronic diseases. The human genome contains more than 2,700 binding sites for active D3; those binding sites are near genes involved in virtually every known major disease of humans.
Vitamin D3 deficiency is defined as having a blood level of 25-OH-D3 of less than 25 ng/ml. Normal is considered 30-50 ng/ml, but most health experts consider a blood level of 50 to 80 ng/ml as the target range for optimal health.
Vitamin D3 Deficiency in the United States
- 70% of the population have insufficient levels of vitamin D (blood levels below 30 ng/ml)
- 50% of the population is vitamin D deficient (blood levels below 25 ng/ml)
- 60% of all hospital patients are vitamin D deficient
- 76% of pregnant mothers are severely vitamin D deficient
- 80% of nursing home patients are vitamin D deficient
- Insufficient exposure to sunlight – our bodies were designed to be exposed to sunlight. Many people now spend most days indoors or are covered up with clothes or sunscreen when outside.
- Residing at a high latitude – reduces sun exposure.
- Aging – the skin as we age gets less responsive to ultraviolet light.
- Darker skin – the skin pigment melanin reduces the effects of ultraviolet rays on the skin, thereby reducing vitamin D formation. The darker the skin, the greater the risk of vitamin D deficiency.
- Obesity, liver disorders, and type 2 diabetes – these conditions reduce the conversion of D3 to 25-OH-D3 by the liver.
Dietary sources of vitamin D3 are insufficient in most circumstances to meet D3 requirements. Sun exposure is highly variable in maintaining adequate blood levels of D3. Supplementation is required in most circumstances. While some people can achieve an optimal level with just 600 IU per day (or 20 minutes of daily sunlight exposure) others may require as much as 10,000 IU per day. Most health experts are recommending supplementation with a dosage of vitamin D3 in the range of 2,000 to 5,000 IU daily. The only way to determine where a person may fall is by testing. Many doctors are now routinely checking the vitamin D status of their patients.
Several meta-analyses have shown that individuals with higher blood levels of vitamin D3 as well as vitamin D3 supplementation are associated with a reduced rate of developing respiratory tract infections due to viruses.1-3 The most well-respected of these studies is a review that appeared in the British Medical Journal.2 Researchers evaluated 25 randomized controlled trials that included 11,321 participants, ranging from infants to individuals 95 years of age. What the researchers discovered was that when individuals with vitamin D deficiency were given daily or weekly vitamin D supplementation, they experienced a 70% decrease in respiratory tract infection rate. In those without vitamin D deficiency, a 25% reduction in respiratory infections was noted after supplementation. Interestingly, in this study, single large dosages (e.g., “bolus” doses greater than 60,000 IU) in adults were NOT effective. This finding illustrates that daily supplementation is preferred.
That said, a 2017 study in the Journal of the American Geriatric Society compared a low dose vs. high dose of vitamin D given as a single monthly dosage to elderly subjects living in a nursing home in a four-year study.3 The high dose group received 100,000 IU of D3 each month (equal to about 3300 IU daily) while the low dose group took an average of 400 to 1,000 IU/day of D3 along with a placebo monthly dose. These results are significant, but given the results seen in other studies, daily supplementation (e.g., at 3,000 IU per day) may have produced even better results than a single monthly dose of 100,000 IU.
There is a considerable focus on immune function in fighting viral illness right now. Not only in our personal lives, but also in medical research. In particular, there is a lot of exciting research coming out.
In two recent studies, mortality rates due to viral respiratory infection were clearly shown to be related to vitamin D3 levels. In the first study, the mortality rate due to viral respiratory tract infection was nearly 100% when vitamin D levels were below 19 ng/ml.4 At 25 ng/ml the death rate was still high at 85% but started dropping rapidly, and by the level of 34 ng/ml there was a 0% mortality rate. This study showed the target for increasing survival when dealing with a respiratory virus is a blood level of 25-OH-D3 of at least 34 ng/ml is critical.
In the second study, a blood level of 25-OH-D3 less than 20 ng/ml on admission to hospital in Belgium was associated with a 3.7-fold increase in the odds of dying from a viral respiratory infection. Overall 59% of the patients admitted for a viral upper respiratory tract infection were vitamin D deficient on admission: 47% of females and 67% of males.
A search of ClinicalTrials.gov reveals there are currently close to 40 ongoing clinical trials looking at vitamin D3 in respiratory tract infections around the world.
Recently, several governments, including the United Kingdom, are considering distributing vitamin D supplementation as a public health strategy to people most at-risk of viral respiratory tract infections. A preliminary report from a program being conducted in nursing homes in the Andalusia region of Spain produced an 82% drop in mortality from respiratory tract infections.
Fortunately, waiting for governments to give away D3 may not be necessary given how affordable it is. The bottom line is that it is critical to get vitamin D level up into the safe zone of at least greater than 34 ng/ml. That usually requires a daily dosage of 2,000 to 5,000 IU of vitamin D3.
- Pham H, Rahman A, Majidi A, Waterhouse M, Neale RE. Acute Respiratory Tract Infection and 25-Hydroxyvitamin D Concentration: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2019;16(17):3020. Published 2019 Aug 21. doi:10.3390/ijerph16173020
- Martineau Adrian R, Jolliffe David A, Hooper Richard L, Greenberg Lauren, Aloia John F, Bergman Peter et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data BMJ 2017; 356 :i6583
- Ginde AA, Blatchford P, Breese K, et al. High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial. J Am Geriatr Soc. 2017;65(3):496–503. doi:10.1111/jgs.14679